Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Cosmos Health - 15 Year Stock Price History | COSM

Historical daily share price chart and data for Cosmos Health since 2010 adjusted for splits and dividends. The latest closing stock price for Cosmos Health as of August 01, 2025 is 0.86.
  • The all-time high Cosmos Health stock closing price was 337.50 on March 13, 2014.
  • The Cosmos Health 52-week high stock price is 1.58, which is 83.7% above the current share price.
  • The Cosmos Health 52-week low stock price is 0.28, which is 67.4% below the current share price.
  • The average Cosmos Health stock price for the last 52 weeks is 0.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Cosmos Health Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.5251 0.6860 0.9300 0.3176 0.8635 29.07%
2024 0.8623 1.3700 1.4600 0.4838 0.6690 -52.55%
2023 2.6324 5.5200 6.8200 0.9900 1.4100 -69.08%
2022 29.4652 95.0000 96.0000 1.8250 4.5600 -94.59%
2021 120.6560 127.5000 192.2500 72.5000 84.2500 -33.92%
2020 75.1304 59.7500 137.2500 28.7500 127.5000 131.82%
2019 77.4871 93.0000 98.7500 55.0000 55.0000 -45.00%
2018 180.4698 270.0000 312.5000 75.0000 100.0000 -60.78%
2017 180.6304 205.0000 266.2500 110.0000 255.0000 24.39%
2016 154.1082 171.2500 205.0000 87.7750 205.0000 2.50%
2015 179.1815 225.0000 235.0000 102.5000 200.0000 -9.09%
2014 268.2806 322.5000 337.5000 217.5000 220.0000 -27.87%
2013 163.9382 62.5000 335.0000 37.5000 305.0000 577.78%
2012 58.7500 62.5000 127.5000 20.0000 45.0000 -64.71%
2011 163.7391 112.5000 300.0000 52.5000 127.5000 -49.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.027B $0.054B
Cosmos Health is a healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices. Cosmos Health, formerly known as Cosmos Holdings Inc., is based in CHICAGO, IL.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.248B 30.48
Zoetis (ZTS) United States $64.907B 24.22
Daiichi Sankyo, - (DSNKY) Japan $46.828B 24.00
Takeda Pharmaceutical (TAK) Japan $43.656B 8.91
BeOne Medicines - (ONC) Cayman Islands $33.004B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.084B 0.00
Summit Therapeutics (SMMT) United States $19.584B 0.00
Merck (MKKGY) Germany $16.168B 11.85
Shionogi (SGIOY) Japan $14.172B 14.20
Neurocrine Biosciences (NBIX) United States $12.718B 37.94
United Therapeutics (UTHR) United States $12.391B 10.72
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.483B 45.76
Grifols, S.A (GRFS) Spain $7.357B 0.00
Corcept Therapeutics (CORT) United States $7.123B 59.44
Ionis Pharmaceuticals (IONS) United States $6.851B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) United States $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
NewAmsterdam Pharma (NAMS) Netherlands $2.449B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.294B 0.00
Ocular Therapeutix (OCUL) United States $1.845B 0.00
Endo (NDOI) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.703B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Dyne Therapeutics (DYN) United States $1.401B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 18.13
Harrow (HROW) United States $1.165B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.017B 0.00
Ardelyx (ARDX) United States $1.014B 0.00
Akebia Therapeutics (AKBA) United States $0.968B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.18
Enliven Therapeutics (ELVN) United States $0.923B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.796B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
Xencor (XNCR) United States $0.592B 0.00
Organogenesis (ORGO) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.568B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
USANA Health Sciences (USNA) United States $0.547B 11.01
Elite Pharmaceuticals (ELTP) United States $0.546B 0.00
Bioventus (BVS) United States $0.536B 13.58
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Savara (SVRA) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.17
AleAnna (ANNA) United States $0.339B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Altimmune (ALT) United States $0.299B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Esperion Therapeutics (ESPR) United States $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.264B 0.00
Nature's Sunshine Products (NATR) United States $0.259B 16.10
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Achieve Life Sciences (ACHV) Canada $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.75
Metagenomi (MGX) United States $0.086B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Telomir Pharmaceuticals (TELO) United States $0.056B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.33
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
FibroGen (FGEN) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.28
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00